Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of automatically notifying women with neurofibromatosis type 1 before their 40th birthday that they are eligible to attend breast cancer screening from the age of 40 years.

Currently women with neurofibromatosis type 1 (NF1) who are considered at moderate or high risk of breast cancer, can be referred through clinical professionals such as specialists in genetics or oncology for annual breast screening which is managed at a local level.

An assessment has not made of the potential merits of automatically notifying women with NF1 before they are 40 years old that they are eligible to attend breast cancer screening from the age of 40 years.